Neurocrine biosciences to present at upcoming investor conferences in september

San diego , aug. 26, 2025 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) will participate at four investor conferences in september. chief financial officer matt abernethy, chief commercial officer eric benevich, and vice-president of investor relations todd tushla will present at the cantor global healthcare conference 2025 at 1:00 p.m.
NBIX Ratings Summary
NBIX Quant Ranking